28222462|t|Decreased Frequencies of Peripheral Blood CD4+CD25+CD127-Foxp3+ in Patients with Graves' Disease and Graves' Orbitopathy: Enhancing Effect of Insulin Growth Factor-1 on Treg Cells
28222462|a|Graves' orbitopathy (GO) is characterized by orbital T cell infiltration. We evaluated the regulatory T (Treg) cell fractions induced with IGF-1 in Graves' disease (GD) with and without GO. Peripheral blood mononuclear cells (PBMCs) were obtained from 13 patients with GD without eye manifestations; 10 patients with active GO; and 12 patients with nodular goiter (NG). All the patients from GD, GO, and NG were subclinical hyperthyroid. We analyzed the expression of Treg cell markers (CD4, CD25, CD127(-), Foxp3) on T cells and their ability to respond to IGF-1 stimulation. In patients with GD without GO, we found lowered percentages of CD4(+) Foxp3(+) cells, as compared to nodular goiter 1.77 vs. 5.42% (p=0.0276). Similarly, significantly reduced frequencies of CD4(+)CD25(+)CD127(-)Foxp3(+) and CD4(+)CD25(+)CD127(-) cells were observed in GD patients as compared to nodular goiter patients with hyperthyreosis, (0.7 vs. 1.48%) (p=0.0071) and (14.5 vs. 37.2%) (p=0.0051), respectively. In GO with active GO, only the percentage of CD4(+)CD25(+)CD127(-) cells was found to be decreased versus nodular goiter (9.35 vs. 37.2) (p=0.0275). Stimulation of PBMC derived from GO patients with IGF-1 resulted in significant increase of frequency of both CD4(+) Foxp3(+) and CD4(+)CD25(+)CD127(-) Foxp3 cells. Decreased frequencies of peripheral blood CD4(+)CD25(+)CD127(-)Foxp3(+) in patients with GD and GO could be an useful marker of autoimmune process and perhaps a possible target for future therapies. This is the first study demonstrating Treg - enhancing effects of IGF-1. Thus IGF-1 can be accounted for modulating Treg cell -related action in GO.
28222462	25	41	Peripheral Blood	T031	UMLS:C0229664
28222462	42	63	CD4+CD25+CD127-Foxp3+	T017	UMLS:C0039198
28222462	81	96	Graves' Disease	T038	UMLS:C0018213
28222462	101	120	Graves' Orbitopathy	T038	UMLS:C0339143
28222462	142	165	Insulin Growth Factor-1	T103	UMLS:C0021665
28222462	169	179	Treg Cells	T017	UMLS:C0039198
28222462	180	199	Graves' orbitopathy	T038	UMLS:C0339143
28222462	201	203	GO	T038	UMLS:C0339143
28222462	225	239	orbital T cell	T017	UMLS:C0039194
28222462	240	252	infiltration	T038	UMLS:C0332448
28222462	257	266	evaluated	T058	UMLS:C0220825
28222462	271	295	regulatory T (Treg) cell	T017	UMLS:C0039198
28222462	319	324	IGF-1	T103	UMLS:C0021665
28222462	328	343	Graves' disease	T038	UMLS:C0018213
28222462	345	347	GD	T038	UMLS:C0018213
28222462	366	368	GO	T038	UMLS:C0339143
28222462	370	404	Peripheral blood mononuclear cells	T017	UMLS:C1321301
28222462	406	411	PBMCs	T017	UMLS:C1321301
28222462	449	451	GD	T038	UMLS:C0018213
28222462	460	478	eye manifestations	T033	UMLS:C0015411
28222462	504	506	GO	T038	UMLS:C0339143
28222462	529	543	nodular goiter	T038	UMLS:C0018023
28222462	545	547	NG	T038	UMLS:C0018023
28222462	572	574	GD	T038	UMLS:C0018213
28222462	576	578	GO	T038	UMLS:C0339143
28222462	584	586	NG	T038	UMLS:C0018023
28222462	621	629	analyzed	T062	UMLS:C0936012
28222462	634	665	expression of Treg cell markers	T058	UMLS:C0600223
28222462	667	670	CD4	T103	UMLS:C0003323
28222462	672	676	CD25	T103	UMLS:C0007507
28222462	678	686	CD127(-)	T103	UMLS:C0083032
28222462	688	693	Foxp3	T103	UMLS:C4282118
28222462	698	705	T cells	T017	UMLS:C0039194
28222462	727	737	respond to	T170	UMLS:C1553423
28222462	738	743	IGF-1	T103	UMLS:C0021665
28222462	774	776	GD	T038	UMLS:C0018213
28222462	785	787	GO	T038	UMLS:C0339143
28222462	821	842	CD4(+) Foxp3(+) cells	T017	UMLS:C0039198
28222462	859	873	nodular goiter	T038	UMLS:C0018023
28222462	949	978	CD4(+)CD25(+)CD127(-)Foxp3(+)	T017	UMLS:C0039198
28222462	983	1010	CD4(+)CD25(+)CD127(-) cells	T017	UMLS:C0039198
28222462	1028	1030	GD	T038	UMLS:C0018213
28222462	1055	1069	nodular goiter	T038	UMLS:C0018023
28222462	1084	1098	hyperthyreosis	T038	UMLS:C0020550
28222462	1177	1179	GO	T038	UMLS:C0339143
28222462	1192	1194	GO	T038	UMLS:C0339143
28222462	1219	1246	CD4(+)CD25(+)CD127(-) cells	T017	UMLS:C0039198
28222462	1280	1294	nodular goiter	T038	UMLS:C0018023
28222462	1338	1342	PBMC	T017	UMLS:C1321301
28222462	1356	1358	GO	T038	UMLS:C0339143
28222462	1373	1378	IGF-1	T103	UMLS:C0021665
28222462	1433	1448	CD4(+) Foxp3(+)	T017	UMLS:C0039198
28222462	1453	1486	CD4(+)CD25(+)CD127(-) Foxp3 cells	T017	UMLS:C0039198
28222462	1513	1529	peripheral blood	T031	UMLS:C0229664
28222462	1530	1559	CD4(+)CD25(+)CD127(-)Foxp3(+)	T017	UMLS:C0039198
28222462	1577	1579	GD	T038	UMLS:C0018213
28222462	1584	1586	GO	T038	UMLS:C0339143
28222462	1599	1612	useful marker	T201	UMLS:C0005516
28222462	1616	1634	autoimmune process	T038	UMLS:C0443146
28222462	1705	1710	study	T062	UMLS:C2603343
28222462	1725	1729	Treg	T017	UMLS:C0039198
28222462	1753	1758	IGF-1	T103	UMLS:C0021665
28222462	1765	1770	IGF-1	T103	UMLS:C0021665
28222462	1792	1802	modulating	T082	UMLS:C0443264
28222462	1803	1812	Treg cell	T017	UMLS:C0039198
28222462	1832	1834	GO	T038	UMLS:C0339143